Position in TRVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18
-$158,612 QoQ
Shares Held
1
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#214
of 216 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dauntless Investment Group, LLC holds $25,152,594 across 19 Biotechnology names. TRVI ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AEON |
AEON Biopharma, Inc.
|
12,490,154 | $8,980,420 | |
| 2 | KZIA |
Kazia Therapeutics Ltd
|
354,208 | $4,987,248 | |
| 3 | ADAG |
Adagene Inc.
|
537,230 | $2,256,366 | |
| 4 | AZTR |
Azitra, Inc.
|
11,292,186 | $1,897,087 | |
| 5 | TLSA |
Tiziana Life Sciences Ltd
|
1,162,000 | $1,487,360 | |
| 6 | ARMP |
Armata Pharmaceuticals, Inc.
|
203,891 | $1,321,213 | |
| 7 | QNRX |
Quoin Pharmaceuticals, Ltd.
|
214,987 | $1,040,537 | |
| 8 | UNCY |
Unicycive Therapeutics, Inc.
|
214,000 | $1,003,660 |
All Filings in TRVI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18 | 1 | Shares | Sole | 2026-08-13 | |
| 2025-06-30 | $158,630 | 29,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||